Every change you make has to be defensible years later.
PeopleSoft upgrades and governance-board structures across life sciences operations. What separates this sector is not complexity, it is evidence: the design decision, the test that proved it and the approval that released it all have to survive an inspection long after everyone involved has moved on. Walk the five decisions, find your seat, then run the two-minute check.
Five calls that decide a life sciences program
Each one determines how much evidence you are creating and whether it will hold. Pick a decision.
Validation scope gets treated as a compliance question answered later, while design proceeds on the assumption that it will be manageable.
Set validation scope with quality in the room before design locks, and write down what is out of scope and why.
Scope decided late is scope decided expensively, because requalifying a design already built costs more than designing to a known boundary. The programs that run well have a documented scope rationale early enough that architects design to it. The ones that struggle discover mid-build that a component everybody assumed was out is in.
Where is our written validation scope rationale, and who from quality signed it?
A change control process built for steady-state operations meets a program generating changes at fifty times the normal rate.
Design a program-scale change path with quality before the build starts, rather than queueing a program through a steady-state process.
This is the single most common schedule killer I see here. The process is not wrong, it is sized for a different volume. Either it becomes the bottleneck and the schedule slips, or people route around it and the evidence trail breaks, which is worse. Agreeing the path up front is cheap and nobody does it.
What is the agreed change throughput for the program, and who agreed it?
Laboratory, manufacturing execution, quality management and serialization systems already exist, each validated, each with its own owner and change cycle.
Name a client-side owner for each interface itself and treat every seam as a validated boundary with its own evidence.
Changing one side of a validated interface has consequences on the other that a normal program would treat as a defect and this sector treats as a deviation. Interfaces owned at each end rather than in the middle are where that gets discovered, usually during qualification.
Who owns each validated interface, by name, and what evidence covers the seam?
Conversion gets scoped by record count and deadline. In this sector the conversion itself has to be evidenced, not just completed.
Design conversion so that the migration is reconstructable and reconciled, with the reconciliation evidence retained rather than discarded after cutover.
The question that arrives later is not whether the data moved, it is whether you can demonstrate that what arrived matches what left, and who approved the exceptions. Programs that reconcile on a spreadsheet and then delete it have completed the task and failed the obligation.
Can we demonstrate, with retained evidence, that converted data matches source?
A cloud platform ships feature releases on the vendor's schedule, not yours, and each one lands on a validated environment.
Staff a permanent regression and requalification capability before go-live, and treat the vendor release calendar as a standing operational commitment.
Workday ships two feature releases annually, in March and September, with a five-week preview window. In a validated environment that is two mandatory regression and requalification cycles a year, permanently. It is the item most reliably missing from post-go-live staffing plans, and the first release after the program team leaves is when that becomes visible.
Who owns regression and requalification for each vendor release, by name?
What those five mean for the chair you sit in
Programs here are judged by inspectors as well as by executives. Each seat's exposure, the early sign, and the question worth asking this quarter.
Evidence is the deliverable
Every design decision, test and approval has to be reconstructable long after the program closes. The failure mode is not a missing control, it is a control that exists without evidence that it operated. Programs routing around a change process because it is slow produce exactly that, and it surfaces during qualification.
Change requests are being batched or expedited informally to protect the schedule.
What is our agreed program change throughput, and is anyone routing around it?
Requalification is a permanent operating cost
The build cost is visible and the run cost is not. Two vendor releases a year in a validated environment means a standing regression and requalification commitment, forever, plus the cost of every adjacent validated interface. If the business case carries build and license only, the year-three number will surprise someone.
The business case has no line for ongoing regression and requalification.
What does this platform cost to run, including requalification, in year three?
Credentials and training records are controlled data
Training completion, qualification status and role-based access are inspection artifacts here, not HR conveniences. They have to survive migration with history intact and stay in sync with what people are permitted to do. Treated as a nice-to-have in design, they become an access control problem with an audit finding attached.
Training and qualification records are scoped as standard HR data with no retention or evidence requirement stated.
Do training and qualification records migrate with full history, and who verified that?
What has to survive after everyone has moved on
Decision four, drawn out. The obligation is not that the work was done well. It is that you can show, years later, that it was done and approved.
Programs fail inspections on the middle two. The work was done; the evidence that it was done was treated as paperwork and handled accordingly.
Four items already on the calendar
None of these are life sciences specific, and all four land harder here because every one of them touches a validated environment.
Engineering stopped at the end of 2025. Moving off it is a reimplementation rather than an upgrade, and any shift-based workforce is in scope.
Extended maintenance runs to 2030 for a fee. If the target platform is a lift and shift of ECC, it arrives with a published expiry date attached.
Oracle support runs past 2036. When an integrator sells urgency on that basis, the pressure is customization debt and scarce skills, not vendor abandonment. Knowing the difference is a negotiating position.
Not a deadline, a treadmill. Two mandatory regression cycles annually, permanently, and the item most reliably missing from a post-go-live staffing plan.
Five questions worth more than a readiness assessment
Answerable from memory, scored on this page, nothing captured and nothing emailed.
These five are the start of the instrument. A full review also covers periodic review, deviation handling, access control design and the adjacent validated system inventory. Or skip the tooling and book the program review.
Running a validated platform program?
Pre-SOW, mid-build, or preparing for qualification with the schedule already tight. I sell no software and staff no builds, so these questions get asked out loud. Tell me where the program is and I will tell you what I see.